Tobramycin Solution
Product Images NDC 70756-604

22 FDA label images from Lifestar Pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 70756-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (68bf90c8 847a 4ea3 8855 C7b380f994dd 01)

Structure (68bf90c8 847a 4ea3 8855 C7b380f994dd 01)
Chemical structure diagram of tobramycin, showing the molecular arrangement of its atoms and bonds consistent with its aminoglycoside antibiotic class.*
FDA Label Image

Figure 1: Relative Change From Baseline In Fev 1% Predicted (68bf90c8 847a 4ea3 8855 C7b380f994dd 02)

Figure 1: Relative Change From Baseline In Fev 1% Predicted (68bf90c8 847a 4ea3 8855 C7b380f994dd 02)
A line graph depicting the average relative change in FEV1 percentage predicted over 24 weeks, comparing Tobramycin Inhalation Solution treatment and placebo groups in two studies. The x-axis shows time in weeks, and the y-axis shows percentage change in FEV1. Data lines indicate higher FEV1 improvement in both Tobramycin groups compared to placebo groups throughout the study period.*
FDA Label Image

Figure 2: Absolute Change From Baseline In Log 10 Cfus (68bf90c8 847a 4ea3 8855 C7b380f994dd 03)

Figure 2: Absolute Change From Baseline In Log 10 Cfus (68bf90c8 847a 4ea3 8855 C7b380f994dd 03)
A line graph depicting average change of Log10 CFUs over 24 weeks from two studies comparing Tobramycin Inhalation Solution treatment to placebo. The x-axis represents weeks, and the y-axis shows average microbiological changes. Tobramycin treatment groups show notable reductions compared to placebo groups during drug administration periods.*
FDA Label Image

Instructions For Use Figure A (68bf90c8 847a 4ea3 8855 C7b380f994dd 04)

Instructions For Use Figure A (68bf90c8 847a 4ea3 8855 C7b380f994dd 04)
An instructional diagram illustrating components of a respiratory inhalation system for Tobramycin solution, USP 300 mg/5 mL. Labeled parts include air compressor, nebulizer cup, inspiratory valve cap, ampule, mouthpiece, tubing, and clean paper or cloth towels, demonstrating setup and usage of the inhalation device.*
FDA Label Image

Instructions For Use Figure B (68bf90c8 847a 4ea3 8855 C7b380f994dd 05)

Instructions For Use Figure B (68bf90c8 847a 4ea3 8855 C7b380f994dd 05)
An instructional illustration showing two hands holding single-use plastic ampules labeled 'Tobramycin Inhalation Solution, USP 300 mg/5 mL.' Arrows indicate a shaking motion to mix the solution inside the ampules before use.*
FDA Label Image

Instructions For Use Figure C (68bf90c8 847a 4ea3 8855 C7b380f994dd 06)

Instructions For Use Figure C (68bf90c8 847a 4ea3 8855 C7b380f994dd 06)
TOBRAMYCIN Tobramycin Inhalation Solution, USP 300 mg/5 mL unit dose vial. The label shows the dosage strength clearly on the vial, with designated fields for expiration date and lot number on the left side of the packaging. The product is intended for respiratory inhalation use.*
FDA Label Image

Instructions For Use Figure D (68bf90c8 847a 4ea3 8855 C7b380f994dd 07)

Instructions For Use Figure D (68bf90c8 847a 4ea3 8855 C7b380f994dd 07)
An instructional diagram showing assembly of a nebulizer device for respiratory inhalation. It labels the Nebulizer Top being placed onto the Nebulizer Cup, with additional labeled parts including the Mouthpiece, Tubing, and Inspiratory Valve Cap. The illustration emphasizes the components involved in preparing the nebulizer for use.*
FDA Label Image

Instructions For Use Figure E (68bf90c8 847a 4ea3 8855 C7b380f994dd 08)

Instructions For Use Figure E (68bf90c8 847a 4ea3 8855 C7b380f994dd 08)
Instructional diagram showing assembly of a nebulizer for inhalation. It depicts hands placing the nebulizer insert into the nebulizer cup, with indications for the top and directional arrows illustrating the insertion process.*
FDA Label Image

Instructions For Use Figure F (68bf90c8 847a 4ea3 8855 C7b380f994dd 09)

Instructions For Use Figure F (68bf90c8 847a 4ea3 8855 C7b380f994dd 09)
An instructional diagram showing parts of a nebulizer for respiratory inhalation use. It depicts a nebulizer cup and a component labeled as the top, placed on a clean paper or cloth towel surface. The illustration provides visual guidance on the assembly or cleaning setup of the nebulizer parts.*
FDA Label Image

Instructions For Use Figure G (68bf90c8 847a 4ea3 8855 C7b380f994dd 10)

Instructions For Use Figure G (68bf90c8 847a 4ea3 8855 C7b380f994dd 10)
An instructional line drawing showing a hand adjusting a knob on a device labeled 'Pulmo Aide,' which is commonly used as a nebulizer compressor for respiratory treatments. The illustration highlights interaction with the device's front panel.*
FDA Label Image

Instructions For Use Figure H (68bf90c8 847a 4ea3 8855 C7b380f994dd 11)

Instructions For Use Figure H (68bf90c8 847a 4ea3 8855 C7b380f994dd 11)
An instructional illustration showing a hand plugging a two-prong electrical plug into a standard wall outlet. An arrow indicates the direction of insertion, likely conveying how to properly connect the device's power cord.*
FDA Label Image

Instructions For Use Figure I (68bf90c8 847a 4ea3 8855 C7b380f994dd 12)

Instructions For Use Figure I (68bf90c8 847a 4ea3 8855 C7b380f994dd 12)
An instructional illustration showing hands holding a single-use vial of Tobramycin inhalation solution, 300 mg/5 mL. The illustration highlights peeling or twisting off a bottom tab to open the vial for respiratory (inhalation) use.*
FDA Label Image

Instructions For Use Figure J (68bf90c8 847a 4ea3 8855 C7b380f994dd 13)

Instructions For Use Figure J (68bf90c8 847a 4ea3 8855 C7b380f994dd 13)
An instructional illustration showing a hand dispensing drops from a small bottle labeled with a lot number into the top opening of a handheld nebulizer. The image demonstrates the proper administration method for a respiratory inhalation solution.*
FDA Label Image

Instructions For Use Figure K (68bf90c8 847a 4ea3 8855 C7b380f994dd 14)

Instructions For Use Figure K (68bf90c8 847a 4ea3 8855 C7b380f994dd 14)
An instructional illustration showing the assembly of a nebulizer device. It labels the nebulizer top with a semi-circle and stem, which is inserted into the nebulizer cup. The nebulizer outlet is also identified, and an arrow indicates the direction to twist the top onto the cup, demonstrating proper nebulizer assembly for inhalation use.*
FDA Label Image

Instructions For Use Figure L (68bf90c8 847a 4ea3 8855 C7b380f994dd 15)

Instructions For Use Figure L (68bf90c8 847a 4ea3 8855 C7b380f994dd 15)
An instructional diagram showing the assembly of a nebulizer for respiratory inhalation. The image labels the mouthpiece and the nebulizer cup, indicating the connection point at the nebulizer outlet.*
FDA Label Image

Instructions For Use Figure M (68bf90c8 847a 4ea3 8855 C7b380f994dd 16)

Instructions For Use Figure M (68bf90c8 847a 4ea3 8855 C7b380f994dd 16)
An instructional diagram showing the placement of an inspiratory valve cap onto a respiratory inhalation device component, likely related to the administration of Tobramycin inhalation solution. The diagram uses arrows to indicate the correct positioning of the valve cap onto the device.*
FDA Label Image

Instructions For Use Figure N (68bf90c8 847a 4ea3 8855 C7b380f994dd 17)

Instructions For Use Figure N (68bf90c8 847a 4ea3 8855 C7b380f994dd 17)
An instructional diagram showing a respiratory inhalation device with labeled air intake, depicting the connection of a mouthpiece and tubing at the bottom. Arrows indicate the direction to connect the tubing to the main inhaler body.*
FDA Label Image

Instructions For Use Figure O (68bf90c8 847a 4ea3 8855 C7b380f994dd 18)

Instructions For Use Figure O (68bf90c8 847a 4ea3 8855 C7b380f994dd 18)
An instructional line drawing showing a hand sliding a tab or switch on a device labeled 'Pulmo Aide,' likely demonstrating a step in using the Pulmo Aide nebulizer or respiratory device.*
FDA Label Image

Instructions For Use Figure P (68bf90c8 847a 4ea3 8855 C7b380f994dd 19)

Instructions For Use Figure P (68bf90c8 847a 4ea3 8855 C7b380f994dd 19)
An instructional illustration showing a respiratory inhalation device emitting a mist or aerosol, demonstrating use likely related to administration of Tobramycin inhalation solution. The device includes a mouthpiece and a handle, with vapor depicted coming out of the mouthpiece.*
FDA Label Image

Instructions For Use Figure Q (68bf90c8 847a 4ea3 8855 C7b380f994dd 20)

Instructions For Use Figure Q (68bf90c8 847a 4ea3 8855 C7b380f994dd 20)
An instructional diagram showing a person using a respiratory inhalation device with a nose clip. The device's mouthpiece is held in the mouth while the nose clip is applied to the nose, illustrating proper inhalation technique for administration.*
FDA Label Image

Pouch Label (68bf90c8 847a 4ea3 8855 C7b380f994dd 21)

Pouch Label (68bf90c8 847a 4ea3 8855 C7b380f994dd 21)
Label for TOBRAMYCIN Inhalation Solution, USP 300 mg/5 mL by Lifestar Pharma LLC. The product is a sterile inhalation solution for nebulizer use, preservative-free, supplied as 4 single-dose 5 mL ampules per pouch. Storage instructions include refrigeration. The label includes manufacturer and contact information, NDC 70756-604-44.*
FDA Label Image

Carton (68bf90c8 847a 4ea3 8855 C7b380f994dd 22)

Carton (68bf90c8 847a 4ea3 8855 C7b380f994dd 22)
Packaging label for Tobramycin Inhalation Solution, USP 300 mg/5 mL by Lifestar Pharma LLC. The label indicates it contains 56 single-dose 5 mL ampules (28-day supply) for inhalation by nebulizer, with no preservatives and sterile. Storage instructions specify refrigeration. Manufactured in Hungary with contact information for Lifestar Pharma.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.